Galeterone

Generic Name
Galeterone
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C26H32N2O
CAS Number
851983-85-2
Unique Ingredient Identifier
WA33E149SW
Background

Galeterone has been used in trials studying the treatment of Prostate Cancer.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

Phase 2
Recruiting
Conditions
Advanced Pancreatic Cancer
Interventions
Drug: galeterone
Drug: Gemcitabine
First Posted Date
2019-09-20
Last Posted Date
2024-06-03
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
58
Registration Number
NCT04098081
Locations
🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: galeterone
First Posted Date
2016-04-06
Last Posted Date
2020-09-04
Lead Sponsor
LTN PHARMACEUTICALS, INC.
Target Recruit Count
6
Registration Number
NCT02729376
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Phase 3
Terminated
Conditions
Prostate Cancer
Interventions
Drug: Enzalutamide
Drug: Galeterone
First Posted Date
2015-05-08
Last Posted Date
2023-03-15
Lead Sponsor
LTN PHARMACEUTICALS, INC.
Target Recruit Count
953
Registration Number
NCT02438007
Locations
🇪🇸

Hospital Clínic i Provincial de Barcelona-Oncology, Barcelona, Spain

🇪🇸

Unidad Cnio Ibima de Investigacion en Prostata, Malaga, Spain

🇪🇸

Hospital General Universitario Gregorio Marañón, Madrid, Spain

and more 112 locations

A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
Drug: galeterone
First Posted Date
2012-10-18
Last Posted Date
2023-03-15
Lead Sponsor
LTN PHARMACEUTICALS, INC.
Target Recruit Count
126
Registration Number
NCT01709734
Locations
🇺🇸

UCLA David Geffen School of Medicine, Los Angeles, California, United States

🇺🇸

University of Maryland, Baltimore, Maryland, United States

🇺🇸

AAHS Research Institute, Annapolis, Maryland, United States

and more 20 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy